REX initiates RAPPER III: Clinical Trial in Multiple Sclerosis
Ethics Committee Approval from NHS’s National Institute for Health Research (NIHR) Partnership with East Kent Hospitals University NHS Foundation Trust, and Kent University Rex Bionics Plc (AIM: RXB), is pleased to announce that the ethics committee of the UK NHS’s National Institute for Health Research has approved the start of a clinical trial to evaluate [...]